Introduction
Transforming growth factor ␤ (TGF ␤ ) is a representative growth inhibitor for many kinds of epithelial cells (Moses et al., 1990 (Moses et al., , 1991 . The signal triggered by TGF ␤ on the cell surface is transduced to the nucleus by a pathway involving Smads (Heldin et al., 1997; Moustakas et al., 2002; Fig. 5 ). The TGF ␤ receptor activated by the ligand binding phosphorylates receptor-restricted Smad2 and Smad3, and the activated Smads dimerize with a co-Smad4 and are translocated to nuclei where they exert their growth inhibitory effect by transcriptional activation of Cdk inhibitors, p21 WAF1/CIP1 and p15 INK4B , and suppression of c-myc (Massague et al., 2000) . For the transcriptional regulation, interaction of Smads with a number of different transacting factors, including Sp1 in particular, is needed (Feng et al., 2000) . When the intracellular signal transduction for TGF ␤ is impaired, epithelial cells undergo aberrant growth and eventually acquire malignant phenotypes (Massague et al., 2000; Pasche, 2001) . Thus, mutation in the type II TGF ␤ 1 receptor was frequently observed in hereditary nonpolypotic colon cancer (Markowitz et al., 1995) . Smad4 was first cloned as a tumor suppressor gene for human pancreatic cancer and was shown to be deleted in 50% of pancreatic cancer cases and 30% of colon cancer cases with high malignancy (Riggins et al., 1997) . In addition to the Smad pathway, a number of cytoplasmic protein kinases, including PKC and MAPKs, have been shown to be involved in TGF ␤ signaling for induction of certain genes (Hanafusa et al., 1999; Ignotz and Honeyman, 2000; Lai and Cheng, 2002; Rosado et al., 2002; Edlund et al., 2003; Yang et al., 2003) .
Recently, we found that Ca 2 ϩ -induced growth inhibition of normal human keratinocytes (NHKs) is mediated by S100C/A11, a Ca 2 ϩ -binding protein with an EF-hand domain (Sakaguchi et al., 2003; Fig. 5 ). On exposure of the cells to high Ca 2 ϩ , cytoplasmic S100C/A11 protein was specifically phosphorylated, bound to nucleolin, and transferred to nuclei. In the nuclei, S100C/A11 liberated Sp1/3 from nucleolin, and the resulting free Sp1/3 transcriptionally activated p21 WAF1/CIP1 , a negative regulator of cell cycle progression.
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TGF ␤ is another representative growth inhibitor for NHK cells. Therefore, we examined whether the S100C/A11 pathway plays any role in TGF ␤ signaling and which protein kinases are responsible for phosphorylation of S100C/A11.
Results and discussion
TGF ␤ 1 inhibits the growth of NHK cells by inducing p21 WAF1/CIP1 via S100C/A11 First, we confirmed the inhibitory action of TGF ␤ 1 on growth of NHK cells (Fig. 1 a) . TGF ␤ 1 dose-dependently inhibited incorporation of [ 3 H]thymidine into an insoluble fraction like high Ca 2 ϩ (Fig. 1 a) , concomitantly inducing p21 WAF1/CIP1 mRNA and protein (Fig. 1, b and c) . Although protein levels of Sp1 (which is known to play a key role with Smads in inducing p21 WAF1/CIP1 ) remained unchanged ( Fig.  1 c) , amounts of activated Sp1 that could bind to a GC-rich region of the p21 WAF1/CIP1 promoter were time-dependently enhanced by TGF ␤ 1 as demonstrated using the chromatin immunoprecipitation method (Fig. 1 d) .
Nuclear translocation of S100C/A11, a hallmark of the involvement of the S100C/A11 pathway (Sakaguchi et al., 2003) , was observed in NHK cells treated with TGF ␤ 1 even at a low dose of 1.0 ng/ml as was observed in cells exposed to high Ca 2 ϩ (Fig. 1 e) . The nuclear translocation of S100C/A11 was confirmed by subfractionation of the cells (Fig. 1 f) . When nucleolin was depleted with siRNA, the nuclear translocation of S100C/A11 was completely blocked (Fig. 1 f) . TGF ␤ 1 induced phosphorylation of S100C/A11 in a time-dependent manner ( Fig. 1 g) . Nucleolin was coprecipitated with the phosphorylated S100C/ A11. In the cells depleted of nucleolin, S100C/A11 remained in the cytoplasm despite the fact that phosphorylation of S100C/A11 by TGF ␤ 1 took place normally (Fig. 1  h) . We demonstrated previously that high Ca 2 ϩ -induced phosphorylation of S100C/A11 at 10 Thr and 94 Ser in human keratinocytes and that only 10 Thr-phosphorylation is relevant to the binding to nucleolin, nuclear translocation, and eventual growth inhibition (Sakaguchi et al., 2003) . A transfection experiment using S100C/A11 expression constructs with mutation at either or both phosphorylation sites demonstrated that the same two sites as those phosphorylated by high Ca 2 ϩ were phosphorylated by TGF ␤ 1 (Fig. 1 i) . These results indicate that the S100C/A11-mediated p21 WAF1/CIP1 -inducing pathway is activated by TGF ␤ 1 in a manner similar to that by high Ca 2 ϩ . Ser were replaced with Ala. S100C/A11-mediated signaling for TGF ␤ | Sakaguchi et al. 981 PKC ␣ mediates the growth inhibitory signal triggered by TGF ␤ 1 and Ca 2 ϩ by phosphorylating S100C/A11 at 10 Thr Next, we performed an experiment to determine which protein kinases phosphorylates S100C/A11 in NHK cells exposed to TGF ␤ 1. When the cells were pretreated with various protein kinase inhibitors, the general protein kinase inhibitor H9 and the classical PKC inhibitor cPKCI, but not a MAPK inhibitor (PD98059) or protein kinase A inhibitor, reduced the TGF ␤ 1-induced phosphorylation level of S100C/A11 (Fig. 2 a) . Activity to phosphorylate S100C/A11 in vitro in cell extracts was recovered in fractions eluted from an anionexchange column with 160-180 mM KCl, in which most PKC species were detected by Western blot analysis (unpublished data). These results prompted us to examine possible phosphorylation of S100C/A11 by PKCs. Among the dozen known PKC species, classical PKC ␣ , novel PKC , PKC ␦ , PKC , and atypical PKC are expressed in skin (Reynolds et al., 1994) . When recombinant proteins of these PKCs were incubated with S100C/A11 in vitro, PKC ␣ , PKC ␦ , and PKC significantly phosphorylated S100C/A11 in an activator-dependent manner (Fig. 2 b) . PKC showed very weak activity and PKC did not phosphorylate to any appreciable extent. To examine possible phosphorylation of S100C/A11 by PKCs in cells, PKC␣, PKC, PKC␦, PKC, and PKC were expressed in NHK cells using an adenovirus vector. Protein levels of PKCs in the transduced cells were 6.5-19-fold higher than those in untreated cells. S100C/A11 was phosphorylated to an appreciable level only in PKC␣-transduced cells in the absence of exogenous stimulation, and the phosphorylation facilitated the association of S100C/A11 to nucleolin (Fig. 2 c) . On exposure of the PKC-transduced cells to TGF␤1, S100C/A11 was strongly phosphorylated in the cells transfected with PKC␣, but all of the other cells showed responsiveness to TGF␤1 similar to that of the control cells transduced with lacZ. Activation of endogenous PKC␣ by TGF␤1 and high Ca 2ϩ was demonstrated by detecting autophosphorylation of PKC␣ (Fig. 2 d) and by translocation of cytosolic PKC␣ to the plasma membrane (Fig. 2 e) . 12-O-tetradecanoylphorbol-13-acetate, an activator of classical and novel PKCs, was used as a positive control.
Using the S100C/A11 expression constructs mutated at the phosphorylation sites, exogenous PKC␣ was shown to phosphorylate 10 Thr but not 94 Ser (Fig. 3 a) . It should be noted that phosphorylation of 10 Thr, but not 94 Ser, is critical for the binding to nucleolin and eventual nuclear translocation (Sakaguchi et al., 2003) . Under the same conditions, exogenous PKC and PKC␦ phosphorylated neither 10 Thr nor 94 Ser (unpublished data). When NHK cells were transfected with the S100C/A11 constructs and exposed to TGF␤1, both 10 Thr and 94 Ser were phosphorylated ( Fig. 1 i  and Fig. 3 b) . Inhibition of PKC␣, the only cPKC expressed in NHK cells, resulted in the blocking of phosphorylation of 10 Thr but not 94 Ser (Fig. 3 b) . Similar results were obtained when the cells were stimulated with 1.5 mM Ca 2ϩ (Fig. 3 c) . To confirm the specificity of PKC␣ further, we transduced a dominant-negative form of PKC␣ (DN-PKC␣) into NHK cells. This DN-PKC␣ was prepared by replacing 369 Lys with Arg and shown to specifically inhibit PKC␣ activity in cells as well as in vitro (Ohno et al., 1990; Garcia-Bermejo et al., 2002) . As shown in Fig. 3 d, phosphorylation of 10 Thr in S100C/A11 was specifically and completely blocked by DN-PKC␣ in NHK cells exposed to TGF␤1 or high Ca 2ϩ . Phosphorylation of S100C/A11 by PKC␣ and autophosphorylation of PKC␣ induced by TGF␤1 do not need de novo protein synthesis (Figs. S1 and S2, available at http:// www.jcb.org/cgi/content/full/jcb.200312041/DC1). These results indicate that PKC␣ is the sole and specific kinase for 10 Thr of S100C/A11 in response to TGF␤1 or high Ca 2ϩ in NHK cells. At present, the precise mechanism of PKC␣ activation is not clear. However, Ca 2ϩ itself is an activator of cPKCs, and the amount of diacylglycerol, another activator for PKCs, was shown to increase in cells exposed to TGF␤1 (Ignotz and Honeyman, 2000) . Chakrabarty et al. (1998) showed that down-regulation of PKC␣ blocked adhesion response of human colon carcinoma cells to TGF␤1.
Relevance of the S100C/A11-mediated pathway to TGF␤1-induced growth inhibition
We examined whether activation of Sp1 through the S100C/ A11-mediated pathway was necessary at all for the growth inhibition induced by TGF␤1. To address this issue, we either inactivated PKC␣ using DN-PKC␣ or an inhibitor or functionally depleted S100C/A11 by introducing a specific anti-S100C/A11 antibody into the cells. As shown in Fig. 3 e, TGF␤1 suppressed DNA synthesis to 27% of the control level, and the inhibition of PKC␣ activity by the dominantnegative construct and cPKC inhibitor resulted in recovery of DNA synthesis to 93% and 86% of the control level, respectively. We demonstrated previously that anti-S100C/A11 antibody blocked phosphorylation and nuclear translocation of S100C/A11 when introduced into cells (Sakaguchi et al., 2003) . Under similar conditions, DNA synthesis was recovered to 85% of the control level by the antibody, whereas IgG showed no effect (Fig. 3 e) . The mitigation of TGF␤1-induced growth inhibition was dependent on doses of the inhibitor and the antibody (unpublished data). p21 WAF1/CIP1 was not induced in the presence of cPKCI or anti-S100C/A11 antibody in TGF␤1-treated cells (Fig. 3 f) . Amount of Sp1 bound to a GC-rich region of the p21 WAF1/CIP1 promoter was reduced by blocking PKC␣ or S100C/A11 as demonstrated using the chromatin immunoprecipitation method (Fig. 3 g) . These results clearly show that the activation of Sp1 in terms of enhanced binding to the p21 WAF1/CIP1 promoter through the S100C/A11-mediated pathway is critically relevant to the inhibition of growth of NHK cells by TGF␤1. were immunoprecipitated with respective antibodies and the precipitates and supernatants that were condensed using acetone were simultaneously analyzed. C, control; TGF, TGF␤1 1 ng/ml; Ca, Ca 2ϩ 1.5 mM. S100C/A11-mediated signaling for TGF␤ | Sakaguchi et al. 983 Smad-mediated pathway is also necessary for TGF␤1-induced growth inhibition When NHK cells were exposed to siRNA against Smad3, the protein level was efficiently down-regulated within 48 h (Fig. S3 , available at http://www.jcb.org/cgi/content/full/ jcb.200312041/DC1). Reduced [ 3 H]TdR incorporation by TGF␤1 (23% of the control level) was substantially mitigated to 63% of the control level by the down-regulation of Smad3 (Fig. 4 a) . The extent was comparable to that by blocking S100C/A11 with an antibody (73%). This profile of DNA synthesis was correlated well with the extent of induction of p21 WAF1/CIP1 and p15 INK4B (Fig. 4 b) . As expected, high Ca 2ϩ -induced growth inhibition does not appear to involve Smad3. These results indicate that the Smad-mediated pathway as well as the S100C/A11-mediated pathway is needed for transduction of the TGF␤1-triggered growthinhibitory signal. The down-regulation of Smad3 did not affect binding of S100C/A11 to and release of Sp1 from nucleolin (Fig. 4, c and e) .
Signal transduction for TGF␤1-and high Ca 2ϩ -induced growth inhibition
Epidermal keratinocytes are one of the most frequently used cells for studying molecular mechanisms of growth regulation in epithelial cells. High Ca 2ϩ and TGF␤ are wellknown representative growth inhibitors for NHK cells, but intracellular signaling pathways for the agents remains surprisingly unclear. A number of distinct but mutually interacting pathways may function involving Ca 2ϩ -dependent proteins, protein kinases, Smads, and other transacting factors (Heldin et al., 1997; Feng et al., 2000; Santini et al., 2001; Moustakas et al., 2002) . This paper, in combination with our previous one (Sakaguchi et al., 2003) , clearly illustrates that the S100C/A11-mediated pathway is not only involved in but also essential for the inhibition of growth of NHK cells by high Ca 2ϩ and TGF␤1 (Fig. 5) . The evidence presented here unequivocally demonstrates that PKC␣ is the sole kinase to phosphorylate 10 Thr of S100C/A11 in NHK cells in response to TGF␤1 and high Ca 2ϩ . Consistent with this, PKC␣ was recently shown to play a necessary role in mediating Ca 2ϩ -induced differentiation of NHK cells (Yang et al., 2003) . Furthermore, Tibudan et al. (2002) demonstrated that PKC␣ was activated during suspension-induced irreversible cell cycle withdrawal in human keratinocytes with concomitant induction of p21 WAF1/CIP1 . In recent years, great progress has been made in the understanding of signal transduction for TGF␤ at molecular levels, revealing the Smad-mediated pathway in particular. There is increasing concern, however, as to whether the Smad pathway is solely responsible for the entire effect of TGF␤. This paper clearly shows that there is a distinct signaling pathway involving PKC␣ and S100C/A11 that leads to activation of Sp1, a key partner of activated Smads for inducing p21 WAF1/CIP1 (Fig. 5 ). Sp1 has long been considered to be a ubiquitous transacting factor. It is true in the sense that Sp1 is involved in transcriptional regulation of diverse genes interacting many different proteins, but it may not be true in the sense that it is functionally available whenever needed. Sp1 protein was present at similar levels in NHK cells before and after stimulation with TGF␤1 ( Fig. 1 c) but bound to the p21 WAF1/CIP1 promoter only after treatment with TGF␤1 ( Fig. 1 d and Fig. 3 g) . The results of this paper may provide a clue for further study to understand complex functional interactions among critical proteins in nuclei.
Materials and methods

Cells and chemicals
NHK cells (KURABO) were cultured in defined keratinocyte-SFM (GIBCO BRL) with defined keratinocyte-SFM growth supplement (GIBCO BRL). For monitoring DNA synthesis, 1 Ci/ml of tritiated thymidine (American Radiolabeled Chemicals) was added to the cultures 1 h before cell harvest. Subfractionation of cells was performed as described previously (Lindeman et al., 1997) . TGF␤1 and H9 (N-[2-aminoethyl]-5-isoquinolinesulfonamide dihydrochloride) were purchased from Sigma-Aldrich and BIOMOL Research Laboratories, Inc., respectively. A myristoylated PKC inhibitor (Eichholtz et al., 1993) , cAMP-dependent kinase peptide inhibitor, and PD98059 (2'-amino-3Ј-methocyflavone; English et al., 1999) were purchased from Promega.
Gel electrophoresis and immunological analyses
Gel electrophoresis, Western blot analysis, and immunoprecipitation were performed under conventional conditions. The antibodies used for Western blot analysis were mouse anti-human nucleolin antibody (Molecular and Biological Laboratories), rabbit anti-human Sp1 antibody (Santa Cruz Biotechnology), mouse anti-human p21 WAF1/CIP1 antibody (BD Biosciences), mouse anti-human tubulin antibody (Sigma-Aldrich), mouse anti-human PCNA antibody (BD Biosciences), and mouse anti-GFP antibody (Sigma-Aldrich). Polyclonal rabbit anti-human S100C antibody was prepared in our laboratory (Sakaguchi et al., 2000) . For immunoprecipitation, rabbit anti-human S100C antibody, rabbit anti-GFP antibody (Molecular and Biological Laboratories), and rabbit anti-human Sp1 antibody (Upstate Biotechnology) were used.
Plasmid and adenovirus constructs
Plasmid expression constructs prepared as described previously (Sakaguchi et al., 2003) were transfected using Trans IT-keratinocyte transfection reagent (Mirus). Preparation and characteristics of adenovirus constructs of PKCs, and preparation of recombinant PKCs and in vitro kinase assay were described previously (Ohba et al., 1998) . Dominant-negative PKC␣ was designed according to Ohno et al. (1990) and the nature of the construct was confirmed in cells (Garcia-Bermejo et al., 2002) .
siRNA
Synthesis of siRNAs against nucleolin and GAPDH was described previously (Sakaguchi et al., 2003) . siRNA against Smad3 (5Ј-aacgtcaacaccaagtgcatc-3Ј) was produced by in vitro transcription using the Silencer siRNA -and TGF␤1-induced growth inhibition in NHK cells. Blue arrows, known from the results of studies by others; black arrows, revealed by our previous paper (Sakaguchi et al., 2003) ; red arrows, demonstrated in the present experiment.
construction kit (Ambion Inc.). The siRNAs were transfected to logarithmically growing NHK cells using Lipofectamine 2000 (Invitrogen).
Introduction of proteins into cells
Cationic polyethylenimine (PEI)-conjugated S100C antibody was used to introduce antibodies into NHK cells.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed according to the method of Takahashi et al. (2000) . In brief, NHK cells were treated with 1% formaldehyde for cross-linking and immunoprecipitated with a rabbit pAb against Sp1 (Santa Cruz Biotechnology). The primers used were those corresponding to positions Ϫ328 to Ϫ309 and Ϫ56 to Ϫ37 of the p21 WAF1/CIP1 promoter.
Acquisition and processing of images
To acquire images of cells labeled with TRITC or FITC, a laser-scanning microscope (Axioplan 2; objective lens, Plan-Apochromat 63ϫ 1.4 oil DC and Plan-Neofluar 40ϫ/0.75; Carl Zeiss MicroImaging, Inc.) was used.
Online supplemental material Fig. S1 shows the effect of cycloheximide on phosphorylation of S100C/ A11 by TGF␤1. Fig. S2 shows the effect of cycloheximide on autophosphorylation of PKC␣ by TGF␤1. Fig. S3 shows the down-regulation of Smad3 protein with siRNA. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200312041/DC1.
